After Covid vaccine, India seeks drug patent waiver Posted on June 14, 2022 As trade negotiators got down to working out a package, India on Monday called for talks for a TRIPS waiver on Covid therapeutics and devices after working out a plan on patent waiver for vaccines.
Leave a Reply